{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:49:24Z","timestamp":1777517364208,"version":"3.51.4"},"reference-count":19,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,9,14]],"date-time":"2007-09-14T00:00:00Z","timestamp":1189728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> The prevalence and timing of cervical dysplasia among substance use disorder (SUD) patients is not well studied.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A cross\u2010sectional pilot survey was undertaken among our primary practice female medical and SUD patients by patient recall of cervical screening history.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> One hundred and fifty\u2010three SUD patients were compared with 77 general medical patients younger than 45 years old. The substances abused in this population have previously been described. There was no difference in the mean number of Pap smears (mean \u00b1 SEM 6.30<jats:italic>\u00a0\u00b1<\/jats:italic>\u00a00.55 vs 5.68<jats:italic>\u00a0\u00b1<\/jats:italic>\u00a00.70, respectively) or the time since last screening (2.93<jats:italic>\u00a0\u00b1<\/jats:italic>\u00a00.29 vs 1.60<jats:italic>\u00a0\u00b1<\/jats:italic>\u00a00.26 years). Limiting the analysis to patients younger than 45 years effectively controlled for the difference in ages between SUD and medical patients (29.94<jats:italic>\u00a0\u00b1<\/jats:italic>\u00a00.52 and 30.21<jats:italic>\u00a0\u00b1<\/jats:italic>\u00a01.04 years). Significant differences in cytological abnormalities (OR\u00a0=\u00a05.88, CI 1.92\u201323.92; <jats:italic>P<\/jats:italic>\u00a0=\u00a00.0005), cervical intraepithelial neoplasia (CIN) (OR\u00a0=\u00a014.4, CI 2.20\u2013602.92, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.001) and high\u2010grade CIN\u2010cancer (<jats:italic>P\u00a0=<\/jats:italic>\u00a00.002) were noted. When diagnoses were scored and charted, the trend of the lines of best fit in the two groups was significantly different (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00.00001). There were five and two cancers noted in the two groups. There were two and ten hysterectomies performed in the two groups which were for two and one indications of cancer, respectively. In the addicted group invasive cancer was diagnosed at 23\u2010, 23\u2010, 34\u2010 and 37\u2010years olds.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> SUD patients have a very high rate of abnormalities on cervical screening including precancerous lesions and these changes occurred at significantly younger ages. The possibility of some form of cancer promotion merits further investigation.<\/jats:p>","DOI":"10.1111\/j.1479-828x.2007.00769.x","type":"journal-article","created":{"date-parts":[[2010,8,28]],"date-time":"2010-08-28T12:33:07Z","timestamp":1282998787000},"page":"419-423","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Lifetime prevalence of cervical neoplasia in addicted and medical patients"],"prefix":"10.1111","volume":"47","author":[{"given":"Albert","family":"REECE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,9,14]]},"reference":[{"key":"e_1_2_2_2_2","first-page":"154","article-title":"Narcotic addiction and cervical carcinoma","volume":"10","author":"Weaver JM","year":"1966","journal-title":"Acta Cytol"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018427320658"},{"key":"e_1_2_2_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089160308900103"},{"key":"e_1_2_2_5_2","doi-asserted-by":"crossref","unstructured":"ReeceAS.Dentition of addiction in Queensland: Poor dental status and major contributing drugs.Aust Dent J2007;52:144\u2013149.","DOI":"10.1111\/j.1834-7819.2007.tb00480.x"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198810000-00003"},{"key":"e_1_2_2_7_2","first-page":"1043","article-title":"Marijuana use and increased risk of squamous carcinoma of the head and neck","volume":"9","author":"Zhang Z","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00181-2"},{"key":"e_1_2_2_9_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.4.2373"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03884"},{"key":"e_1_2_2_11_2","unstructured":"WilsonQMet\u00a0al.Combination of Morphine and delta\u20109\u2010tetrahydrocannabinol has super\u2010 and sub\u2010additive effects on immunosuppression. College of the Problems of Drug Dependence Meeting Bal Harbour Florida June 2003 Abstract 744 p186."},{"key":"e_1_2_2_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02098025"},{"key":"e_1_2_2_13_2","unstructured":"United Nations Office of DrugsandCrime(UNODC).World Drug Report 2006 \u2013 Global Illicit Drug Trends. Vienna Austria:UNODC 2006."},{"key":"e_1_2_2_14_2","doi-asserted-by":"crossref","unstructured":"MorimotoS TanakaY SasakiKet al.Identification and characterization of cannabinoids that induce cell death through mitochondrial permeability transition in Cannabis leaf cells.J Biol Chem2007;282:20739\u201320751.","DOI":"10.1074\/jbc.M700133200"},{"key":"e_1_2_2_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00371.2005"},{"key":"e_1_2_2_16_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00157.2002"},{"key":"e_1_2_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2005.03.008"},{"key":"e_1_2_2_18_2","first-page":"347","volume-title":"Marijuana and Medicine. Totowa, NJ","author":"Zimmerman AM","year":"1999"},{"key":"e_1_2_2_19_2","first-page":"141","volume-title":"Management of Drug and Alcohol Problems","author":"Todd F","year":"2002"},{"key":"e_1_2_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(91)90010-D"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1479-828X.2007.00769.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1479-828X.2007.00769.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T03:45:34Z","timestamp":1697082334000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1479-828X.2007.00769.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,14]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1479-828X.2007.00769.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1479-828x.2007.00769.x","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,14]]},"assertion":[{"value":"2007-09-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}